AVYCAZ

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Feb 25, 2015

   11 yr 6 mo ago

2. Patent 7112592 expires

   Listed drug substance patent expiration.

   Jan 07, 2026

   5 mo ago

3. Patent 7112592 expires

   Listed drug substance patent expiration.

   Jan 07, 2026

   5 mo ago

4. Patent 7112592 expires

   Listed drug substance patent expiration.

   Jan 07, 2026

   5 mo ago

5. Patent 7112592 expires

   Listed drug substance patent expiration.

   Jan 07, 2026

   5 mo ago

6. Today

7. Patent 7612087 expires

   Listed drug product patent expiration.

   Nov 12, 2026

   in 5 mo

8. Exclusivity ends · NPP

   New patient population exclusivity (3 years)

   Jan 26, 2027

   in 7 mo

9. Patent 8835455 expires

   Listed drug product patent expiration.

   Oct 08, 2030

   in 4 yr 4 mo

10. Patent 8471025 expires

    Listed drug substance patent expiration.

    Aug 12, 2031

    in 5 yr 3 mo

11. Patent 8969566 expires

    Listed drug substance patent expiration.

    Jun 15, 2032

    in 6 yr 1 mo

12. Patent 9284314 expires

    Listed drug substance patent expiration.

    Jun 15, 2032

    in 6 yr 1 mo

13. Patent 9695122 expires

    Listed drug substance patent expiration.

    Jun 15, 2032

    in 6 yr 1 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (1)

• NPPNew patient population exclusivity (3 years)

  Jan 26, 2027

  in 7 mo

Listed patents (10)